NCT03074864 Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC Status UNKNOWN Phase PHASE2/PHASE3
NCT03064854 PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients Status TERMINATED Phase PHASE1
NCT03060343 Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase EARLY_PHASE1
NCT03056300 A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies Status COMPLETED Phase NA
NCT03053804 Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction Status UNKNOWN Phase NA
NCT03048136 A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT03042221 Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy Status RECRUITING Phase N/A
NCT03017885 Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy Status COMPLETED Phase N/A
NCT03006575 Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT03003468 Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 Status COMPLETED Phase PHASE1/PHASE2
NCT03001882 An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT02988635 Early Palliative Care on Quality of Life of Advanced Cancer Patients Status COMPLETED Phase PHASE3
NCT02978196 99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC Status COMPLETED Phase EARLY_PHASE1
NCT02974725 A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma Status TERMINATED Phase PHASE1
NCT02968979 Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer. Status COMPLETED Phase N/A
NCT02961270 Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation Status UNKNOWN Phase PHASE2